MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$26,861K
Net Income
-$7,273K
Net Profit Margin
-27.08%
EPS
-$0.71
Unit: Thousand (K) dollars
Revenue Breakdown
Diagnostic Tests
Development Services
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
26,861
25,555
28,755
21,768
Direct costs and expenses
4,820
4,205
4,879
4,106
Research and development
3,135
3,285
2,870
2,992
Sales, marketing, general and administrative
24,282
24,261
22,972
21,714
Impairment loss on intangible assets
12
5
1
7
Total operating expenses
32,249
31,756
30,722
28,819
Loss from operations
-5,388
-6,201
-1,967
-7,051
Interest expense
1,982
1,977
2,059
2,074
Change in fair value of warrant liability, net
-
-
-140*
-
Other income , net
-
-
-94*
-
Other income, net
97
385
-
409
Total other expense
-1,885
-1,592
-2,013
-1,665
Net loss
-7,273
-7,793
-3,980
-8,716
Basic EPS
-0.71
-0.81
-0.527
-1.16
Diluted EPS
-0.71
-0.81
-0.527
-1.16
Basic Average Shares
10,296,000
9,656,000
7,551,000*
7,500,000
Diluted Average Shares
10,296,000
9,656,000
7,551,000*
7,500,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$7,273K
(36.58%↑ Y/Y)
Diagnostic Tests
$25,349K
(41.63%↑ Y/Y)
Development Services
$1,512K
(-28.68%↓ Y/Y)
Loss from operations
-$5,388K
(44.56%↑ Y/Y)
Total other expense
-$1,885K
(-7.78%↓ Y/Y)
Revenues
$26,861K
(34.18%↑ Y/Y)
Other income, net
$97K
(90.20%↑ Y/Y)
Total operating
expenses
$32,249K
(8.45%↑ Y/Y)
Interest expense
$1,982K
(4.43%↑ Y/Y)
Sales, marketing,
general and...
$24,282K
(8.35%↑ Y/Y)
Direct costs and
expenses
$4,820K
(19.57%↑ Y/Y)
Research and development
$3,135K
(-4.10%↓ Y/Y)
Impairment loss on
intangible assets
$12K
(-53.85%↓ Y/Y)
Buy us a coffee
BIODESIX INC (BDSX)
BIODESIX INC (BDSX)